Qi Nathan, Franczyk Michael P, Yamaguchi Shintaro, Kojima Daiki, Hayashi Kaori, Satoh Akiko, Ogiso Noboru, Kanda Takeshi, Sasaki Yo, Finck Brian N, DeBosch Brian J, Yoshino Jun
Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, United States.
Center for Human Nutrition, Washington University School of Medicine, St. Louis, Missouri, United States.
Am J Physiol Endocrinol Metab. 2024 Jul 1;327(1):E81-E88. doi: 10.1152/ajpendo.00313.2023. Epub 2024 May 29.
Nicotinamide adenine dinucleotide (NAD) is a universal coenzyme regulating cellular energy metabolism in many cell types. Recent studies have demonstrated the close relationships between defective NAD metabolism and aging and age-associated metabolic diseases. The major purpose of the present study was to test the hypothesis that NAD biosynthesis, mediated by a rate-limiting NAD biosynthetic enzyme, nicotinamide phosphoribosyltransferase (NAMPT), is essential for maintaining normal adipose tissue function and whole body metabolic health during the aging process. To this end, we provided in-depth and comprehensive metabolic assessments for female adipocyte-specific knockout (ANKO) mice during aging. We first evaluated body fat mass in young (≤4-mo-old), middle aged (10-14-mo-old), and old (≥18-mo-old) mice. Intriguingly, adipocyte-specific deletion protected against age-induced obesity without changing energy balance. However, data obtained from the hyperinsulinemic-euglycemic clamp procedure (HECP) demonstrated that, despite the lean phenotype, old ANKO mice had severe insulin resistance in skeletal muscle, heart, and white adipose tissue (WAT). Old ANKO mice also exhibited hyperinsulinemia and hypoadiponectinemia. Mechanistically, loss of caused marked decreases in WAT gene expression of lipogenic targets of peroxisome proliferator-activated receptor gamma (PPAR-γ) in an age-dependent manner. In addition, administration of a PPAR-γ agonist rosiglitazone restored fat mass and improved metabolic abnormalities in old ANKO mice. In conclusion, these findings highlight the importance of the NAMPT-NAD-PPAR-γ axis in maintaining functional integrity and quantity of adipose tissue, and whole body metabolic function in female mice during aging. Defective NAD metabolism is associated with aging and age-associated metabolic diseases. In the present study, we provided in-depth metabolic assessments in female mice with adipocyte-specific inactivation of a key NAD biosynthetic enzyme NAMPT and revealed an unexpected role of adipose tissue NAMPT-NAD-PPAR-γ axis in maintaining functional integrity and quantity of adipose tissue and whole body metabolic health during the aging process.
烟酰胺腺嘌呤二核苷酸(NAD)是一种普遍存在的辅酶,可调节多种细胞类型中的细胞能量代谢。最近的研究表明,NAD代谢缺陷与衰老及年龄相关的代谢性疾病之间存在密切关系。本研究的主要目的是验证以下假设:由限速NAD生物合成酶烟酰胺磷酸核糖基转移酶(NAMPT)介导的NAD生物合成对于在衰老过程中维持正常脂肪组织功能和全身代谢健康至关重要。为此,我们对衰老过程中的雌性脂肪细胞特异性敲除(ANKO)小鼠进行了深入而全面的代谢评估。我们首先评估了年轻(≤4月龄)、中年(10 - 14月龄)和老年(≥18月龄)小鼠的体脂量。有趣的是,脂肪细胞特异性缺失可预防年龄诱导的肥胖,而不改变能量平衡。然而,从高胰岛素-正常血糖钳夹实验(HECP)获得的数据表明,尽管老年ANKO小鼠表现出瘦型表型,但在骨骼肌、心脏和白色脂肪组织(WAT)中存在严重的胰岛素抵抗。老年ANKO小鼠还表现出高胰岛素血症和低脂联素血症。从机制上讲,NAMPT缺失导致WAT中过氧化物酶体增殖物激活受体γ(PPAR-γ)的脂肪生成靶点基因表达以年龄依赖性方式显著降低。此外,给予PPAR-γ激动剂罗格列酮可恢复老年ANKO小鼠的脂肪量并改善代谢异常。总之,这些发现突出了NAMPT-NAD-PPAR-γ轴在维持衰老雌性小鼠脂肪组织的功能完整性和数量以及全身代谢功能方面的重要性。NAD代谢缺陷与衰老及年龄相关的代谢性疾病有关。在本研究中,我们对关键NAD生物合成酶NAMPT脂肪细胞特异性失活的雌性小鼠进行了深入的代谢评估,并揭示了脂肪组织NAMPT-NAD-PPAR-γ轴在衰老过程中维持脂肪组织功能完整性和数量以及全身代谢健康方面的意外作用。